Drugs / Flu Quadrivalent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04984408 | Oct 2021 → Sep 2024 | COVID-19 | International Vaccine Institute | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flu Quadrivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04984408 ↗ |
| Known as | Influenza Vaccine | “The southern hemisphere for the 2021 influenza season quadrivalent Influenza Vaccine (Flu Quadrivalent)” NCT04984408 ↗ |
| Modality | Vaccine | “quadrivalent Influenza Vaccine (Flu Quadrivalent)” NCT04984408 ↗ |
| Route | Intramuscular | “Mode of Administration: Intramuscular” NCT04984408 ↗ |